Insys opioid lawsuit settlement
Insys Settles Illinois Opioid Lawsuit for $4.5 Million
August 7, 2017
Drugmaker Insys will pay $4.5 million to settle allegations of deceptively marketing its fentanyl-based cancer medication in a lawsuit brought by Illinois Attorney General Lisa Madigan.
The Arizona pharmaceutical manufacturer has been in a great deal of legal trouble lately, most of it stemming from several of its former officers confessing to having participated in a scheme to bribe doctors to promote its powerful opioid medication Subsys. Six former execs of the company have pleaded guilty, but former CEO Michael Babich and others have pleaded not guilty.
Subsys was the focus of the Illinois suit, as well, in which Madigan alleged that Insys had marketed the drug for purposes for which it had not received approval from the U.S. Food and Drug Administration (FDA).
Just this week, Insys, still an extant company, released a new drug called Syndros. The active ingredient in Syndros is THC, the active ingredient in cannabis; Insys intends the drug to be used for the treatment of chemotherapy-induced nausea.
Opioid addiction claims the lives of some 30,000 Americans every year.
If you or a loved one has suffered the horrors of opioid addiction, contact TheLawFirm.com. We know how to help you.
Click For A Free Consultation!
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!